Clinical trial

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

NCT01422733

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2018-06-01

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2018-06-01Date precision: day

Registry last updated2018-07-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hyperandrogenemiaunresolved

Obesityunresolved

Polycystic Ovary Syndromeunresolved

Interventions

HydrocortisoneDRUG · verified · RxNorm: hydrocortisone

dexamethasoneDRUG · verified · RxNorm: dexamethasone

CosyntropinDRUG · verified · RxNorm: cosyntropin

rhCGDRUG

Sponsors & collaborators

University of Virginialead sponsor

Mapped research locations

CharlottesvilleVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01422733 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.